Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GS.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.21.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EE.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ES.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.41NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.19.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.479NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.437NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.371NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.625NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.443NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.495NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.294NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.453NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.350NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.304NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.315NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.516NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.354NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.162NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.426NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.402NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.424NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.264NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.581NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.330NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.205NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.177NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.301NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.308NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.210NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.325NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.590NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.116NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.496NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used